Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke

In 1995, the NINDS (National Institute of Neurological Disorders and Stroke) tPA (tissue plasminogen activator) Stroke Study Group published the results of a large multicenter clinical trial demonstrating efficacy of intravenous tPA by revealing a 30% relative risk reduction (absolute risk reduction...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, Sherita N, Mehndiratta, Prachi, Johansen, Michelle C, McMurry, Timothy L, Johnston, Karen C, Southerland, Andrew M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938499/
https://www.ncbi.nlm.nih.gov/pubmed/24591838
http://dx.doi.org/10.2147/VHRM.S39213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938499/
https://www.ncbi.nlm.nih.gov/pubmed/24591838
http://dx.doi.org/10.2147/VHRM.S39213

Ejemplares similares